Relations between Sodium Transport and Sodium Concentration in Human Erythrocytes in Health and Disease

1981 ◽  
Vol 60 (5) ◽  
pp. 555-564 ◽  
Author(s):  
M. Cumberbatch ◽  
D. B. Morgan

1. We have examined the inter-relationships between erythrocyte sodium content and sodium transport in a group of healthy subjects and in groups of patients with disorders known to change the sodium content of erythrocytes. 2. In the healthy subjects the sodium content of erythrocytes was inversely related to both the permeability of the erythrocyte membrane to sodium (as measured by the unidirectional, ouabain-sensitive, sodium efflux) and the total activity of the sodium pumps (as measured by the rate constant of ouabain-sensitive sodium efflux). There was a correlation between the total activity of the sodium pumps and the membrane permeability to sodium. 3. Changes in the erythrocyte sodium content were due to a decrease in the activity of the sodium pumps (as in hypokalaemia and digoxin treatment), or a decrease in the permeability of the erythrocyte membrane to sodium (as in chronic renal failure) or a reduction of both the membrane permeability and the number of sodium pumps (as in hyperthyroidism or elderly patients). 4. One interpretation of the results in the healthy subjects is that there are two components of sodium influx; one associated with the sodium pumps in what we have called ‘membrane-units’ and the other determined by the ground permeability of the membrane. 5. On the basis of this model we suggest that in the geriatric and hyperthyroid patients there is a reduction in the number of ‘membrane-units’, that in hypokalaemia and during digoxin treatment there is inhibition of the sodium-pump component of the ‘membrane-units’ and that in chronic renal failure there is a decrease in the permeability of the membrane to sodium.

1982 ◽  
Vol 62 (5) ◽  
pp. 489-494 ◽  
Author(s):  
R. Swaminathan ◽  
G. Clegg ◽  
M. Cumberbatch ◽  
Z. Zareian ◽  
F. McKenna

1. Erythrocyte sodium, sodium transport (ouabain-sensitive efflux rate of sodium, oMosNa, and ouabain-sensitive efflux rate constant of sodium, oMosNa), sodium-potassium activated ouabain-sensitive adenosine triphosphatase (Na+, K+-ATPase) activity and [3H]ouabain-binding capacity were measured in 15 patients with chronic renal failure and in 10 healthy subjects. 2. As a group, patients with chronic renal failure had a lower erythrocyte sodium and oMosNa compared with healthy subjects. 3. When patients were divided according to their erythrocyte sodium (greater or less than 4 mmol/kg of cells), in the group of patients whose erythrocyte sodium was less than 4 mmol/kg of cells (group A) the oMosNa was higher than that in healthy subjects and the oMosNa, Na+, K+-ATPase activity and [3H]ouabain-binding capacity were the same as those in healthy subjects. In the subgroup of patients with renal failure whose erythrocyte sodium content was greater than 4 mmol/kg of cells (group B) the oMosNa was less and plasma urea concentration higher than in group A and Na+, K+-ATPase activity, [3H]ouabain-binding capacity and oMosNa were lower than in healthy subjects. 4. These results suggest that in early chronic renal failure there is stimulation of ‘sodium pumps’ (without alteration in their number), which causes a lowering of erythrocyte sodium content, and that as the disease progresses there is inhibition of the ‘sodium pumps’ as well as a reduction in membrane permeability so that erythrocyte sodium is near normal.


1975 ◽  
Vol 49 (3) ◽  
pp. 213-216 ◽  
Author(s):  
R. P. S. Edmondson ◽  
P. J. Hilton ◽  
N. F. Jones ◽  
J. Patrick ◽  
R. D. Thomas

1. In sixteen patients with severe chronic renal failure the rate constant for total sodium efflux from leucocytes was significantly reduced compared with that in thirty control subjects. This difference lay chiefly in the glycoside-sensitive (‘active’) moiety of sodium efflux. 2. In sixteen patients receiving regular haemodialysis, the rate constant for total sodium efflux from the leucocyte was significantly greater than in the undialysed uraemic patients though still subnormal. 3. In individual patients, an increase in sodium efflux could be detected as early as 1 week after regular haemodialysis was started. 4. These results are compatible with the existence of a dialysable molecule in uraemic plasma affecting leucocyte sodium transport.


1982 ◽  
Vol 62 (1) ◽  
pp. 101-107 ◽  
Author(s):  
P. A. Jackson ◽  
D. B. Morgan

1. The cholesterol and phospholipid content of the cell membrane and the efflux of sodium were measured in the erythrocytes of patients with chronic cholestasis and in healthy subjects. 2. The membranes from the patients contained more cholesterol and phospholipid and had a higher cholesterol/phospholipid molar ratio than the membranes from the healthy subjects. 3. The sodium efflux rate constant was reduced in the patients and this was entirely due to a reduction in the frusemide-sensitive efflux rate constant. There was no difference in either the ouabain-sensitive or the ouabain plus frusemide-resistant rate constants. 4. This reduction in the frusemide-sensitive rate constant was associated with a reduction in the erythrocyte sodium content. 5. When erythrocytes were loaded with cholesterol in vitro the frusemide-sensitive efflux rate constant was reduced by an amount similar to that observed in the patients. In addition, however, there was a reduction in the ouabain-sensitive efflux rate constant and an increase in the erythrocyte sodium content; neither of these changes was observed in the patients in vivo.


Author(s):  
Kenichi Kariya ◽  
Hiroshi Sano ◽  
Junji Yamanishi ◽  
Komei Saito ◽  
Yutaka Furuta ◽  
...  

Author(s):  
Elżbieta Kimak ◽  
Andrzej Książek ◽  
Janusz Solski

AbstractStudies were carried out in 183 non-dialyzed, 123 hemodialysis, 81 continuous ambulatory peritoneal dialysis and 35 post-transplant patients and in 103 healthy subjects as a reference group. Lipids and apolipoprotein (apo)AI and apoB were determined using Roche kits. An anti-apoB antibody was used to separate apoB-containing apoCIII and apoE-triglyceride-rich lipoprotein (TRL) in the non-high-density lipoprotein (non-HDL) fraction from apoCIIInonB and apoEnonB in the HDL fraction in four groups of patients with chronic renal failure (CRF) and healthy subjects. Multivariate linear regression analysis was used to investigate the relationship between triglyceride (TG) or HDL-cholesterol (HDL-C) concentrations and lipoproteins. Dyslipidemia varied according to the degree of renal insufficiency, the type of dialysis and therapy regime in CRF patients. Lipoprotein disturbances were manifested by increased TG, non-HDL-C and TRL concentrations, and decreased HDL-C and apoAI concentrations, whereas post-renal transplant patients showed normalization of lipid and lipoprotein profiles, except for TG levels and total apoCIII and apoCIIInonB. The present study indicates that CRF patients have disturbed lipoprotein composition, and that hypertriglyceridemia and low HDL-C concentrations in these patients are multifactorial, being secondary to disturbed lipoproteins. The method using anti-apoB antibodies to separate apoB-containing lipoproteins in the non-HDL fraction from non-apoB-containing lipoproteins in HDL can be used in the diagnosis and treatment of patients with progression of renal failure or atherosclerosis. The variability of TG and HDL-C concentrations depends on the variability of TRL and cholesterol-rich lipoprotein concentrations, but the decreases in TG and increases in HDL-C concentrations are caused by apoAI concentration variability. These relationships, however, need to be confirmed in further studies.


2016 ◽  
Vol 6 (4) ◽  
pp. 01
Author(s):  
Tiago Rozendo Evangelista ◽  
Antônio Ricardo Lisboa ◽  
Antônia Elinaide Ferreira Dantas ◽  
Itatyane Batista de Oliveira ◽  
Elvira Uchoa dos Anjos

<p>A Insuficiência Renal Crônica (IRC) é uma doença crônica, progressiva, debilitante, que causa incapacidades e que apresenta alta taxa de mortalidade, sendo que a incidência e prevalência têm aumentado ainda mais na população mundial, relacionada a histórico familiar, sedentarismo, dieta com alto teor de sódio, assim como taxas alteradas de ureia e creatinina, bem como outros fatores que se relacionam com a história clínica e individual. O número de pacientes em tratamento hemodialítico vem aumentando gradualmente ao longo dos anos, sendo a hemodiálise o tratamento mais comum, os pacientes vivenciam mudanças bruscas na sua vida influenciando de forma considerável na qualidade de vida do portador de IRC. O presente trabalho tem como objetivo avaliar a repercussão do tratamento hemodialítico na vida dos pacientes com Insuficiência Renal Crônica. A pesquisa foi realizada no Centro de Hemodiálise do Hospital Regional de Cajazeiras. Os dados foram coletados após a aprovação do CEP, sob o protocolo nº1.515.907. Para a coleta de dados foi utilizado um roteiro de entrevista semiestruturado contendo informações a respeito de fatores sócios demográficos, bem como questões pertinentes ao tratamento hemodialítico. Os dados qualitativos foram organizados conforme a técnica e análise de dados de LEFEVRE; LEFEVRE e analisados mediante leitura pertinente. A pesquisa seguiu a Resolução 466/12 do Conselho Nacional de Saúde que trata de pesquisas desenvolvidas com seres humanos. A hemodiálise repercute de forma significativa na vida do portador de DRC, influenciando de várias maneiras desde aspectos clínicos, como social, financeiro e emocional.</p><p><strong><em>Impact of hemodialysis in the lives of patients with chronic renal failure in Paraiba Hinterland</em></strong></p><p><strong>Abstract </strong>Chronic Renal Failure (CRF) is a chronic, progressive, debilitating disease which causes disabilities and has a high mortality rate, and the incidence and prevalence have increased even more in the world population, related to family background, physical inactivity, diet high sodium content, as well as altered rates of urea and creatinine and other factors that are related to clinical and personal history. The number of patients in hemodialytic treatment has been increasing gradually over the years, in which hemodialysis is the most common treatment. Patients experience sudden changes in their lives influencing considerably in the quality of life of the IRC carrier. To assess the repercussion of hemodialytic treatment in the lives of patients with Chronic Renal Failure. The research was conducted in the Hemodialysis Center at Regional Hospital of Cajazeiras. For the data collection a semi-structured interview guide was used, containing information about social and economic factors, as well as issues related to hemodialytic treatment. The qualitative data were organized according to the technique and data analysis of LEFEVRE; LEFEVRE and analyzed through relevant reading. The research followed the Resolution 466/12 of the National Health Council, which deals with researches conducted on human subjects. A better understanding and characterization of the factors related to the repercussion of the hemodialytic treatment in the lives of the patients affected by Chronic Renal Failure.</p>


1972 ◽  
Vol 43 (3) ◽  
pp. 311-318 ◽  
Author(s):  
M. A. Needle ◽  
W. Shapiro ◽  
V. Viswanathan ◽  
M. Semar

1. Erythrocytes were incubated in buffers with different [bicarbonate]/[chloride] ratios. 2. The erythrocyte sodium content was higher in buffers with higher [bicarbonate]/ [chloride] ratios. 3. The rise in erythrocyte sodium concentration with increase in [bicarbonate]/[chloride] ratio was independent of the effects of ouabain and ouabain plus ethacrynic acid. Primaquine-induced changes in membrane permeability, ATP depletion by starvation and the use of potassium-free buffers did not change the effect. 4. The results may demonstrate a system which either increases the permeability of erythrocytes to sodium or regulates the sodium content of erythrocytes by a carrier system which is independent of ATP.


1985 ◽  
Vol 69 (s12) ◽  
pp. 13P-13P
Author(s):  
T.H. Thomas ◽  
C. Mason ◽  
K.M. Illingworth

2004 ◽  
Vol 107 (6) ◽  
pp. 583-588 ◽  
Author(s):  
Mats JOHANSSON ◽  
Sinsia A. GAO ◽  
Peter FRIBERG ◽  
Marita ANNERSTEDT ◽  
Göran BERGSTRÖM ◽  
...  

Patients with CRF (chronic renal failure) are at increased risk of cardiovascular diseases, and 60% of cardiovascular mortality in CRF is attributed to sudden death. Various abnormalities in myocardial repolarization are associated with the risk of ventricular arrhythmia. The aim of this study was to evaluate an index of temporal myocardial repolarization lability, the temporal QTVI (QT variability index), in patients with CRF. ECGs were recorded in 153 patients with CRF on haemodialysis (n=67), continuous ambulatory peritoneal dialysis (n=43) or conservative treatment (n=43) during 30 min of rest. QTVI was calculated as the logarithm of the ratio between the variances of the normalized QT and RR intervals. Age-matched healthy subjects (n=39) were examined for comparison. QTVI was increased by 47% in CRF patients compared with healthy subjects (−0.82±0.56 compared with −1.54±0.27 respectively; P<0.01). QTVI did not differ among patients on dialysis or conservative treatment, whereas QTVI was elevated further in patients with diabetes compared with non-diabetic CRF patients (−0.56±0.54 compared with −0.94±0.52 respectively; P<0.01). In a multiple linear regression analysis, diabetes and a history of coronary artery disease were the only independent predictors of QTVI in the CRF population. The present study demonstrates that elevated QTVI in patients with CRF is associated with diabetes and coronary disease. The present findings are important given that repolarization instability may predispose to ventricular arrhythmia and sudden death, events that occur frequently in CRF patients.


1990 ◽  
Vol 511 ◽  
pp. 223-231 ◽  
Author(s):  
Michele Petrarulo ◽  
Ornella Bianco ◽  
Martino Marangella ◽  
Sergio Pellegrino ◽  
Franco Linari ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document